- 57
- 23 121
veedacr
India
Приєднався 8 лис 2014
Veeda Clinical Research Limited (“Veeda”) together with its subsidiary, Bioneeds India Private Limited (“Bioneeds”), and its joint venture, Ingenuity Biosciences Private Limited (“Ingenuity”), (together referred to as the “Veeda Group”) offers a comprehensive portfolio of clinical, preclinical and bio/analytical services to support innovator, biosimilar and generic drug development programs of our global clientele.
We are an independent, institutional investors owned, Board governed and professionally managed contract research group offering scientific leadership, global quality management systems and long term operational and financial stability through a continuing investment in our people, processes, systems, infrastructure, technology and a deep commitment to quality.
Visit our website to learn more about Veeda: www.veedacr.com/
We are an independent, institutional investors owned, Board governed and professionally managed contract research group offering scientific leadership, global quality management systems and long term operational and financial stability through a continuing investment in our people, processes, systems, infrastructure, technology and a deep commitment to quality.
Visit our website to learn more about Veeda: www.veedacr.com/
Webinar: Advanced Analytical Characterization Technique for Biopharmaceutical Development | Veeda
The webinar, "Advanced Analytical Characterization Techniques for Biopharmaceutical Development," was a comprehensive exploration of state-of-the-art methodologies shaping the future of the biopharmaceutical industry.
It provided an in-depth look at innovative analytical approaches and their application in tackling complex challenges associated with biopharmaceutical development.
The session began with a discussion on biosimilar development, emphasizing the critical role of regulatory insights in ensuring analytical comparability and compliance.
Experts shared valuable perspectives on navigating the evolving regulatory landscape while maintaining the quality and efficacy of biosimilar products.
A significant focus was placed on High-Resolution Mass Spectrometry (HRMS) for molecular characterization. The webinar highlighted how HRMS has become a cornerstone in identifying and quantifying product variants, offering unparalleled precision in molecular analysis.
Another key topic was the assessment of higher-order structures (HOS). The speakers delved into advanced techniques for evaluating protein structures, stressing the importance of HOS in ensuring the safety and efficacy of biopharmaceutical products. The discussion underscored the critical role of structural analysis in maintaining product integrity.
Finally, the webinar addressed the analytical challenges posed by complex biopharmaceuticals. Industry leaders shared innovative strategies and case studies, showcasing how advanced tools and methodologies can successfully overcome these challenges, ensuring robust and reliable product characterization.
This engaging and insightful webinar provided participants with actionable knowledge and practical techniques to advance their expertise in biopharmaceutical development, paving the way for enhanced product quality and innovation in the field.
Visit our website ➦ www.veedacr.com/
If you like this video, do not forget to thumbs up, comment, and share this video.
Get notified of our new videos, click subscribe, and press the bell icon. www.youtube.com/@veedacr
➦ Get social with us:
◉ Facebook: veedacr/
◉ Instagram: veedacr
◉ Twitter: veedacr/
◉ LinkedIn: www.linkedin.com/company/veedacr/
◉ UA-cam: www.youtube.com/@veedacr
➦ Tags and Keywords:
#BiopharmaceuticalDevelopment #AnalyticalCharacterization #BiosimilarDevelopment #RegulatoryInsights #HRMS #MolecularCharacterization #HigherOrderStructures #ProteinStructureAnalysis #AnalyticalChallenges #ComplexBiopharmaceuticals #ProductQualityAssurance #BiopharmaceuticalInnovation #EfficacyAndSafety #StructuralAnalysis #AdvancedAnalyticalMethodologies #ComparabilityStudies #BiopharmaceuticalRND #CaseStudies #QualityAndCompliance #InnovativeAnalyticalSolutions
It provided an in-depth look at innovative analytical approaches and their application in tackling complex challenges associated with biopharmaceutical development.
The session began with a discussion on biosimilar development, emphasizing the critical role of regulatory insights in ensuring analytical comparability and compliance.
Experts shared valuable perspectives on navigating the evolving regulatory landscape while maintaining the quality and efficacy of biosimilar products.
A significant focus was placed on High-Resolution Mass Spectrometry (HRMS) for molecular characterization. The webinar highlighted how HRMS has become a cornerstone in identifying and quantifying product variants, offering unparalleled precision in molecular analysis.
Another key topic was the assessment of higher-order structures (HOS). The speakers delved into advanced techniques for evaluating protein structures, stressing the importance of HOS in ensuring the safety and efficacy of biopharmaceutical products. The discussion underscored the critical role of structural analysis in maintaining product integrity.
Finally, the webinar addressed the analytical challenges posed by complex biopharmaceuticals. Industry leaders shared innovative strategies and case studies, showcasing how advanced tools and methodologies can successfully overcome these challenges, ensuring robust and reliable product characterization.
This engaging and insightful webinar provided participants with actionable knowledge and practical techniques to advance their expertise in biopharmaceutical development, paving the way for enhanced product quality and innovation in the field.
Visit our website ➦ www.veedacr.com/
If you like this video, do not forget to thumbs up, comment, and share this video.
Get notified of our new videos, click subscribe, and press the bell icon. www.youtube.com/@veedacr
➦ Get social with us:
◉ Facebook: veedacr/
◉ Instagram: veedacr
◉ Twitter: veedacr/
◉ LinkedIn: www.linkedin.com/company/veedacr/
◉ UA-cam: www.youtube.com/@veedacr
➦ Tags and Keywords:
#BiopharmaceuticalDevelopment #AnalyticalCharacterization #BiosimilarDevelopment #RegulatoryInsights #HRMS #MolecularCharacterization #HigherOrderStructures #ProteinStructureAnalysis #AnalyticalChallenges #ComplexBiopharmaceuticals #ProductQualityAssurance #BiopharmaceuticalInnovation #EfficacyAndSafety #StructuralAnalysis #AdvancedAnalyticalMethodologies #ComparabilityStudies #BiopharmaceuticalRND #CaseStudies #QualityAndCompliance #InnovativeAnalyticalSolutions
Переглядів: 123
Відео
Webinar: Multiple Myeloma: Opportunities and Challenges in the Changing Treatment Landscape | Veeda
Переглядів 191Місяць тому
Discover key takeaways from our recent webinar on Multiple Myeloma: Opportunities and Challenges in the Changing Treatment Landscape. Hear expert insights into the latest advancements, evolving treatment strategies, and the future of care for patients with Multiple Myeloma. Visit our website ➦ www.veedacr.com/ If you like this video, do not forget to thumbs up, comment, and share this video. Ge...
Podcast: Developing Liraglutide: A GLP-1 Peptide for Type 2 Diabetes Management | Veeda Group
Переглядів 57Місяць тому
Liraglutide has demonstrated remarkable efficacy in managing Type 2 Diabetes Mellitus, and Veeda Group has been at the forefront of supporting the development of complex drugs like Liraglutide for more than a decade. Till date, Veeda Group has conducted 15 glucose clamp studies across a variety of insulin products, including Insulin Glargine, Insulin Aspart, and Wosulin. In addition to our work...
Advanced Strategies in Bioanalysis of Biosimilars: Achieving Similarity Through Robust Assays
Переглядів 1514 місяці тому
In our recently concluded webinar, participants gained invaluable insights into the significance of robust bioanalytical assays in ensuring biosimilarity. Attendees explored advanced strategies for optimizing bioanalytical methods to achieve precise and reliable results. The session also covered key regulatory considerations and expectations in the bioanalysis of biosimilars, equipping particip...
Celebrating 400 Clinical Studies: Veeda Group's Mehsana Unit Reaches New Heights
Переглядів 1736 місяців тому
Veeda Group's Mehsana Clinical Research Unit proudly announces the completion of 400 clinical studies, marking a significant milestone in their journey of excellence. The celebration was led by Veeda Clinical Research's CEO, Mr. Ajay Tandon, along with Dr. Jatin Vadhvana, Head of the Clinical Research Department, and Dr. Sunil Soitawala, Incharge of the Mehsana Unit. They commended the entire M...
Webinar: Biomarkers and Endpoint Assessment in Complex Generic Trials | Veeda
Переглядів 1907 місяців тому
Biomarker assessments have revolutionized drug discovery, development, and approval. For diseases as complex as Chronic Obstructive Pulmonary Disease (COPD), assessing biomarkers and endpoints is essential for demonstrating safety, efficacy, and equivalence to the reference product. Step into the forefront of modern medicine and watch this webinar on Biomarkers and Endpoints Assessments in COPD...
Webinar: Bioanalytical Method Development and Validation for Respiratory Drugs | Veeda
Переглядів 1508 місяців тому
Gain valuable insights from our experts and ensure your Respiratory drug development is streamlined. Watch our webinar on Bioanalytical Method Development & Validation for Respiratory Drugs: Achieving Sensitivity, Selectivity, and Reproducibility. Explore: - Current analytical techniques used for Respiratory drug analysis and future emerging trends - Factors affecting the development of optimal...
Veeda Group Acquires European CRO Heads
Переглядів 3678 місяців тому
Join us as we embark on an exhilarating journey of innovation and excellence in delivering end-to-end drug development services on a global scale. We cordially invite you to watch and listen to our Group CEO, Dr. Mahesh Bhalgat, as he shares insightful comments on Veeda's recent acquisition of Health Data Specialists (Heads), a Europe-based CRO recognized as a global leader in Oncology Trials. ...
Webinar: Immunogenicity Risk Assessment for Innate Immune Response Modulating Impurities (IIRMI)
Переглядів 1449 місяців тому
Uncover the key aspects and register today for this exclusive webinar on Immunogenicity Risk Assessment for Innate Immune Response Modulating Impurities (IIRMI), hosted by our Biopharma expert, which promises an insightful exploration of key topics: • Introduction to Immunogenicity and IIRMI & Importance of Immunogenicity Risk Assessment • Cell Models for IIRMI Assessment • USFDA Recommendation...
Podcast: Veeda Biopharma's Integrated Development Solutions for Biologics, Biosimilars and Vaccines
Переглядів 8310 місяців тому
Discover insights from Biopharma experts in our latest podcast, covering Discovery Biology, Clinical Bioanalysis, Analytics, and Characterization solutions. Explore why Veeda Biopharma is the ideal partner for your Biopharmaceutical Development journey. Key Highlights of this Podcast episode: • Unique Insights from Biopharma Experts: Listen to our Biopharma professionals as they delve into Veed...
Veeda Biopharma Capabilities | A fully Integrated Biopharma Division of Veeda Clinical Research
Переглядів 205Рік тому
Welcome to the world of Veeda Biopharma, the biopharmaceutical division of Veeda Clinical Research! 🌟 In this video, we're excited to introduce you to the powerhouse that stands at the forefront of scientific excellence and cutting-edge infrastructure. 🔬 Discover how Veeda Biopharma is committed to providing tailored solutions, expertly navigating the intricate global R&D landscapes, and making...
Veeda's Clinical Research Unit in Mehsana, Gujarat
Переглядів 1,3 тис.Рік тому
If you like this video, do not forget to give a thumbs up, comment, and share this video. Get notified of our new videos, click subscribe, and press the bell icon. www.youtube.com/@veedacr ➦ Get social with us: ◉ Facebook: veedacr/ ◉ Instagram: veedacr ◉ Twitter: veedacr/ ◉ LinkedIn: www.linkedin.com/company/veedacr/ ◉ UA-cam: www.youtube.com/@veedacr
Mini Podcast: Building Trust in Clinical Trials: Veeda's Purposeful Tech Integration | Veeda
Переглядів 53Рік тому
In a recent episode of our podcast series dedicated to the intricacies of drug development, we took a comprehensive look at the effective management and monitoring of clinical trials through the lens of Clinical Trial Management Systems (CTMS). Our guest, a seasoned Deputy Clinical Manager from a leading clinical research organization, shared valuable experiences from past projects, emphasizing...
Symposium: Phase I Trials for Emerging BioPharmas | Veeda
Переглядів 233Рік тому
In this video, key representatives and experts come together for a symposium focusing on integrated phase I trial solutions for emerging biopharmaceuticals. Hosted by Veeda Clinical in collaboration with the Atal Incubation Center, the symposium addresses the challenges faced during the development of new chemical entities and large molecules. Viewers will get a comprehensive understanding of t...
Webinar: Generating Patient Narratives in the Clinical Trails by Using SAS Programming | Veeda
Переглядів 407Рік тому
In this informative webinar, viewers will gain insights into the use of SAS programming for creating patient narratives in the context of clinical trials. The session is led by an experienced Principal Statistical Programmer with a decade of expertise in statistical programming for clinical development. The speaker highlights the importance of patient narratives in clinical study reporting, emp...
Webinar: Lung Cancer Clinical Trials Evaluating Efficacy and Overcoming Resistance | Veeda
Переглядів 203Рік тому
Webinar: Lung Cancer Clinical Trials Evaluating Efficacy and Overcoming Resistance | Veeda
Mini-Podcast on Navigating Bioanalytical Challenges: Unbound Paclitaxel Quantification
Переглядів 64Рік тому
Mini-Podcast on Navigating Bioanalytical Challenges: Unbound Paclitaxel Quantification
Mini-Podcast on First-in-Human Trial for Vitiligo
Переглядів 73Рік тому
Mini-Podcast on First-in-Human Trial for Vitiligo
Webinar on Challenges & Considerations in Designing & Conducting Phase II Immuno Oncology Trial
Переглядів 176Рік тому
Webinar on Challenges & Considerations in Designing & Conducting Phase II Immuno Oncology Trial
Podcast on Addressing Key Challenges of Conducting First Monoclonal Antibody (Omalizumab) Study
Переглядів 149Рік тому
Podcast on Addressing Key Challenges of Conducting First Monoclonal Antibody (Omalizumab) Study
Webinar on Managing Challenging Bioanalysis for PKPD Assessments of New Chemical Entities
Переглядів 273Рік тому
Webinar on Managing Challenging Bioanalysis for PKPD Assessments of New Chemical Entities
Webinar: First in Man Studies - Strategies for a Successful Outcome | Veeda
Переглядів 582Рік тому
Webinar: First in Man Studies - Strategies for a Successful Outcome | Veeda
Webinar: Long Acting Injectable-Antipsychotics | Veeda
Переглядів 355Рік тому
Webinar: Long Acting Injectable-Antipsychotics | Veeda
Webinar on Comparative Clinical Endpoint and Pharmacodynamic Bioequivalence Studies
Переглядів 255Рік тому
Webinar on Comparative Clinical Endpoint and Pharmacodynamic Bioequivalence Studies
Mini Podcast: Identifying the Right Investigators and Patients for your Vaccine Study | Veeda
Переглядів 180Рік тому
Mini Podcast: Identifying the Right Investigators and Patients for your Vaccine Study | Veeda
Mini Podcast: Complex Assay Development | Method Development Challenges For Calcitriol | Veeda
Переглядів 118Рік тому
Mini Podcast: Complex Assay Development | Method Development Challenges For Calcitriol | Veeda
Webinar: The Growing Prominence of TKIs and its Bioequivalence Studies | Veeda
Переглядів 1092 роки тому
Webinar: The Growing Prominence of TKIs and its Bioequivalence Studies | Veeda
Webinar - Tyrosine Kinase Inhibitors (TKIs) - Veeda
Переглядів 952 роки тому
Webinar - Tyrosine Kinase Inhibitors (TKIs) - Veeda
Webinar: Bioanalytical Aspects of BA/ BE Studies for Endogenous Molecule | Veeda
Переглядів 3382 роки тому
Webinar: Bioanalytical Aspects of BA/ BE Studies for Endogenous Molecule | Veeda
Webinar: Data Safety Assessment in Clinical Trials | Veeda
Переглядів 1062 роки тому
Webinar: Data Safety Assessment in Clinical Trials | Veeda
Can you please tell what is status as of now of this medicine. I am a vitiligo patient.
Mare stadi karvi6 contact aapso
Contact aapone
Are bhai Gujarat me ho to Gujarati ma bolo samjay kato Hindi language Ma
Nahi ❤
Muje 50,000 wali study karni he
બીજા ઉપર રિસર્જ કરો છો પેલા પોતાની ઉપર કરો ને કેમ બીક લાગે છે 400. ને 500 ml બ્લડ લેતા
બ્લડ લે વેચ કરો છો એ દેખાડો ને બંધ કરો લોહી લેવાનું મેહસાણા વિડા કંપની વાળા હવે કાયદે સર કામ થશે તને પૈસા ની લાલચ માં નાખો છો પબ્લિક ને 300 ml માં 30 હજાર ને 40હજાર આટલા ભાગ ને આબધુ બંધ કરો
Great👍